337 related articles for article (PubMed ID: 25399643)
1. Targeting protein kinases with selective and semipromiscuous covalent inhibitors.
Miller RM; Taunton J
Methods Enzymol; 2014; 548():93-116. PubMed ID: 25399643
[TBL] [Abstract][Full Text] [Related]
2. Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors.
Liu R; Yue Z; Tsai CC; Shen J
J Am Chem Soc; 2019 Apr; 141(16):6553-6560. PubMed ID: 30945531
[TBL] [Abstract][Full Text] [Related]
3. Selectively Targeting the Kinome-Conserved Lysine of PI3Kδ as a General Approach to Covalent Kinase Inhibition.
Dalton SE; Dittus L; Thomas DA; Convery MA; Nunes J; Bush JT; Evans JP; Werner T; Bantscheff M; Murphy JA; Campos S
J Am Chem Soc; 2018 Jan; 140(3):932-939. PubMed ID: 29232121
[TBL] [Abstract][Full Text] [Related]
4. Fragment-based approaches to the discovery of kinase inhibitors.
Mortenson PN; Berdini V; O'Reilly M
Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
[TBL] [Abstract][Full Text] [Related]
5. The Cysteinome of Protein Kinases as a Target in Drug Development.
Chaikuad A; Koch P; Laufer SA; Knapp S
Angew Chem Int Ed Engl; 2018 Apr; 57(16):4372-4385. PubMed ID: 28994500
[TBL] [Abstract][Full Text] [Related]
6. Electrophilic fragment-based design of reversible covalent kinase inhibitors.
Miller RM; Paavilainen VO; Krishnan S; Serafimova IM; Taunton J
J Am Chem Soc; 2013 Apr; 135(14):5298-301. PubMed ID: 23540679
[TBL] [Abstract][Full Text] [Related]
7. A structural atlas of kinases inhibited by clinically approved drugs.
Wang Q; Zorn JA; Kuriyan J
Methods Enzymol; 2014; 548():23-67. PubMed ID: 25399641
[TBL] [Abstract][Full Text] [Related]
8. Reversible lysine-targeted probes reveal residence time-based kinase selectivity.
Yang T; Cuesta A; Wan X; Craven GB; Hirakawa B; Khamphavong P; May JR; Kath JC; Lapek JD; Niessen S; Burlingame AL; Carelli JD; Taunton J
Nat Chem Biol; 2022 Sep; 18(9):934-941. PubMed ID: 35590003
[TBL] [Abstract][Full Text] [Related]
9. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
Bailey FP; Andreev VI; Eyers PA
Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
[TBL] [Abstract][Full Text] [Related]
10. Determining Cysteines Available for Covalent Inhibition Across the Human Kinome.
Zhao Z; Liu Q; Bliven S; Xie L; Bourne PE
J Med Chem; 2017 Apr; 60(7):2879-2889. PubMed ID: 28326775
[TBL] [Abstract][Full Text] [Related]
11. Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors.
Leproult E; Barluenga S; Moras D; Wurtz JM; Winssinger N
J Med Chem; 2011 Mar; 54(5):1347-55. PubMed ID: 21322567
[TBL] [Abstract][Full Text] [Related]
12. Reactive Chemical Probes: Beyond the Kinase Cysteinome.
Jones LH
Angew Chem Int Ed Engl; 2018 Jul; 57(30):9220-9223. PubMed ID: 29644769
[TBL] [Abstract][Full Text] [Related]
13. Reversible covalent inhibition of a protein target.
Lee CU; Grossmann TN
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8699-700. PubMed ID: 22806944
[No Abstract] [Full Text] [Related]
14. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
Dar AC; Shokat KM
Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
[TBL] [Abstract][Full Text] [Related]
15. Covalent docking of large libraries for the discovery of chemical probes.
London N; Miller RM; Krishnan S; Uchida K; Irwin JJ; Eidam O; Gibold L; Cimermančič P; Bonnet R; Shoichet BK; Taunton J
Nat Chem Biol; 2014 Dec; 10(12):1066-72. PubMed ID: 25344815
[TBL] [Abstract][Full Text] [Related]
16. Developing irreversible inhibitors of the protein kinase cysteinome.
Liu Q; Sabnis Y; Zhao Z; Zhang T; Buhrlage SJ; Jones LH; Gray NS
Chem Biol; 2013 Feb; 20(2):146-59. PubMed ID: 23438744
[TBL] [Abstract][Full Text] [Related]
17. The 'retro-design' concept for novel kinase inhibitors.
Müller G; Sennhenn PC; Woodcock T; Neumann L
IDrugs; 2010 Jul; 13(7):457-66. PubMed ID: 20582870
[TBL] [Abstract][Full Text] [Related]
18. Catalytic mechanisms and regulation of protein kinases.
Wang Z; Cole PA
Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
[TBL] [Abstract][Full Text] [Related]
19. Structural approaches to obtain kinase selectivity.
Norman RA; Toader D; Ferguson AD
Trends Pharmacol Sci; 2012 May; 33(5):273-8. PubMed ID: 22503441
[TBL] [Abstract][Full Text] [Related]
20. High-throughput kinase profiling as a platform for drug discovery.
Goldstein DM; Gray NS; Zarrinkar PP
Nat Rev Drug Discov; 2008 May; 7(5):391-7. PubMed ID: 18404149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
